{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:38:12Z","timestamp":1795084692172,"version":"4.10.2"},"reference-count":96,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1720,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1111\/j.1365-2796.2010.02313.x","type":"journal-article","created":{"date-parts":[[2010,11,10]],"date-time":"2010-11-10T17:38:20Z","timestamp":1289410700000},"page":"16-28","source":"Crossref","is-referenced-by-count":117,"title":["Blocking interleukin-1\u03b2 in acute and chronic autoinflammatory diseases"],"prefix":"10.1111","volume":"269","author":[{"given":"C. A.","family":"Dinarello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,12,16]]},"reference":[{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"7907","DOI":"10.1073\/pnas.81.24.7907","article-title":"Nucleotide sequence of human monocyte interleukin 1 precursor cDNA","volume":"81","author":"Auron","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/312458a0","article-title":"Cloning and expression of murine interleukin-1 cDNA in Escherichia coli","volume":"312","author":"Lomedico","year":"1984","journal-title":"Nature"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1073\/pnas.74.10.4624","article-title":"Human leukocytic pyrogen: purification and development of a radioimmunoassay","volume":"74","author":"Dinarello","year":"1977","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1084\/jem.150.3.709","article-title":"Adherent cell function in murine T-lymphocyte antigen recognition. IV. Enhancement of murine T-cell antigen recognition by human leukocytic pyrogen","volume":"150","author":"Rosenwasser","year":"1979","journal-title":"J Exp Med"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB5|cit5","first-page":"167","volume-title":"Induction of Serum Amyloid A Synthesis by Human Leukocytic Pyrogen, in Bacterial Endotoxins and Host Response","author":"McAdam","year":"1980"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJM198411293112205","article-title":"Interleukin-1 and the pathogenesis of the acute-phase response","volume":"311","author":"Dinarello","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1084\/jem.154.3.631","article-title":"Studies of endotoxin-induced decrease in lipoprotein lipase activity","volume":"154","author":"Kawakami","year":"1981","journal-title":"J Exp Med"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1084\/jem.162.6.2163","article-title":"Cachectin\/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts","volume":"162","author":"Dayer","year":"1985","journal-title":"J Exp Med"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/351355b0","article-title":"Drosophila Toll and IL-1 receptor","volume":"351","author":"Gay","year":"1991","journal-title":"Nature"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1126\/science.2969618","article-title":"cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily","volume":"241","author":"Sims","year":"1988","journal-title":"Science"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB11|cit11","first-page":"311","article-title":"Internalization and nuclear localization of interleukin 1 are not sufficient for function","volume":"2","author":"Heguy","year":"1991","journal-title":"Cell Growth Differ"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/S0021-9258(18)45924-8","article-title":"Amino acids conserved in interleukin-1 receptors (IL-1Rs) and the Drosophila toll protein are essential for IL-1R signal transduction","volume":"267","author":"Heguy","year":"1992","journal-title":"J Biol Chem"},{"issue":"suppl 9","key":"10.1111\/j.1365-2796.2010.02313.x-BIB13|cit13","first-page":"S289","article-title":"Anakinra reduces the rate of joint destruction after 1\u2003year of treatment in a randomized controlled cohort of patients with rheumatoid arthritis","volume":"43","author":"Bresnihan","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"suppl 1","key":"10.1111\/j.1365-2796.2010.02313.x-BIB14|cit14","first-page":"169","article-title":"Treatment with anakinra reduces the rate of joint destruction and shows accelerated benefit in the second 6\u2003months of treatment for patients with rheumatoid arthritis","volume":"40","author":"Genant","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.4049\/jimmunol.163.9.5049","article-title":"IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation","volume":"163","author":"Joosten","year":"1999","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/rheumatology\/41.9.972","article-title":"Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage","volume":"41","author":"Abramson","year":"2002","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 2","key":"10.1111\/j.1365-2796.2010.02313.x-BIB17|cit17","first-page":"ii22","article-title":"Clinical and radiological effects of anakinra in patients with rheumatoid arthritis","volume":"42","author":"Bresnihan","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0002-9440(10)63357-3","article-title":"Interleukin-18 promotes joint inflammation and induces interleukin-1-driven cartilage destruction","volume":"165","author":"Joosten","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB19|cit19","first-page":"237","article-title":"The role of cytokines in osteoarthritis pathophysiology","volume":"39","author":"Fernandes","year":"2002","journal-title":"Biorheology"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/art.24096","article-title":"Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study","volume":"61","author":"Chevalier","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.25.022106.141627","article-title":"Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease","volume":"27","author":"Masters","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ng756","article-title":"Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome","volume":"29","author":"Hoffman","year":"2001","journal-title":"Nat Genet"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","article-title":"Germline mutations in the extracellular domains of the 55\u2003kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes","volume":"97","author":"McDermott","year":"1999","journal-title":"Cell"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/art.20033","article-title":"Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra","volume":"50","author":"Hawkins","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJMoa055137","article-title":"Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition","volume":"355","author":"Goldbach-Mansky","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0140-6736(04)17401-1","article-title":"Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist prevents","volume":"364","author":"Hoffman","year":"2004","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1056\/NEJM200306193482523","article-title":"Interleukin-1 receptor antagonist in the Muckle-Wells syndrome","volume":"348","author":"Hawkins","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/art.23687","article-title":"Efficacy and safety of rilonacept (interleukin-1 trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies","volume":"58","author":"Hoffman","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa0810787","article-title":"Use of canakinumab in the cryopyrin-associated periodic syndrome","volume":"360","author":"Lachmann","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/art.23437","article-title":"The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis","volume":"58","author":"Gattorno","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.4049\/jimmunol.139.6.1902","article-title":"Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro","volume":"139","author":"Dinarello","year":"1987","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1084\/jem.163.6.1433","article-title":"Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1","volume":"163","author":"Dinarello","year":"1986","journal-title":"J Exp Med"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nm1603","article-title":"Identification of a key pathway required for the sterile inflammatory response triggered by dying cells","volume":"13","author":"Chen","year":"2007","journal-title":"Nat Med"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1073\/pnas.0915018107","article-title":"Differential release of chromatin-bound IL-1alpha discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation","volume":"107","author":"Cohen","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1182\/blood.V84.12.4242.bloodjournal84124242","article-title":"Interleukin-1 induces interleukin-8 from endothelial cells by a juxacrine mechanism","volume":"84","author":"Kaplanski","year":"1994","journal-title":"Blood"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1074-7613(04)00046-9","article-title":"NALP3 forms an IL-1\u03b2 processing inflammasome with increased activity in Muckle-Wells auto-inflammatory disorder","volume":"20","author":"Agostini","year":"2004","journal-title":"Immunity"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","article-title":"Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade","volume":"201","author":"Pascual","year":"2005","journal-title":"J Exp Med"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1182\/blood-2008-03-146720","article-title":"Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages","volume":"113","author":"Netea","year":"2009","journal-title":"Blood"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.1074\/jbc.M109.064907","article-title":"Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1beta","volume":"285","author":"Okamoto","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1002\/art.22842","article-title":"Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations","volume":"56","author":"Gattorno","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.4049\/jimmunol.165.8.4615","article-title":"ATP acts as an agonist to promote stimulus-induced secretion of IL-1 beta and IL-18 in human blood","volume":"165","author":"Perregaux","year":"2000","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1084\/jem.20082481","article-title":"In vivo regulation of interleukin 1beta in patients with cryopyrin-associated periodic syndromes","volume":"206","author":"Lachmann","year":"2009","journal-title":"J Exp Med"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/MED.0b013e32833bf6dc","article-title":"Role of IL-1b in type 2 diabetes","volume":"17","author":"Dinarello","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1210\/er.2007-0033","article-title":"Cytokines and beta-cell biology: from concept to clinical translation","volume":"29","author":"Donath","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF02427283","article-title":"Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans","volume":"29","author":"Mandrup-Poulsen","year":"1986","journal-title":"Diabetologia"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1172\/JCI200215318","article-title":"Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets","volume":"110","author":"Maedler","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1210\/en.2009-0543","article-title":"Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I","volume":"150","author":"Boni-Schnetzler","year":"2009","journal-title":"Endocrinology"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1210\/jc.2008-0396","article-title":"Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation","volume":"93","author":"Boni-Schnetzler","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"8138","DOI":"10.1073\/pnas.0305683101","article-title":"Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets","volume":"101","author":"Maedler","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.2337\/diabetes.53.7.1706","article-title":"Glucose- and interleukin-1beta-induced beta-cell apoptosis requires Ca2+ influx and extracellular signal-regulated kinase (ERK) 1\/2 activation and is prevented by a sulfonylurea receptor 1\/inwardly rectifying K+ channel 6.2 (SUR\/Kir6.2) selective potassium channel opener in human islets","volume":"53","author":"Maedler","year":"2004","journal-title":"Diabetes"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cyto.2009.07.567","article-title":"The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity","volume":"48","author":"Stienstra","year":"2009","journal-title":"Cytokine"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.4049\/jimmunol.168.4.1984","article-title":"Autocrine induction of the human pro-IL-1beta gene promoter by IL-1beta in monocytes","volume":"168","author":"Toda","year":"2002","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1038\/oby.2010.55","article-title":"The effect of the interleukin-1 cytokine family members IL-1F6 and IL-1F8 on adipocyte differentiation","volume":"18","author":"van Asseldonk","year":"2010","journal-title":"Obesity"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa065213","article-title":"Interleukin-1-receptor antagonist in type 2 diabetes mellitus","volume":"356","author":"Larsen","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/dc09-0533","article-title":"Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes","volume":"32","author":"Larsen","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB56|cit56","first-page":"A30","article-title":"XOMA 052, a potential disease modifying anti-1L-1beta antibody, shows sustained HbA1c reductions 3 Months after a single injection with no increases in safety parameters in subjects with Type 2 diabetes","volume":"58","author":"Donath","year":"2009","journal-title":"Diabetes"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1152\/physiol.00032.2009","article-title":"Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes","volume":"24","author":"Donath","year":"2009","journal-title":"Physiology (Bethesda)"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1210\/endo.139.12.6336","article-title":"An in vivo model for elucidation of the mechanism of tumor necrosis factor-alpha (TNF-alpha)-induced insulin resistance: evidence for differential regulation of insulin signaling by TNF-alpha","volume":"139","author":"Cheung","year":"1998","journal-title":"Endocrinology"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2353\/ajpath.2006.050293","article-title":"Severely impaired insulin signaling in chronic wounds of diabetic ob\/ob mice: a potential role of tumor necrosis factor-alpha","volume":"168","author":"Goren","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/jhep.2003.50048","article-title":"Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease","volume":"37","author":"Li","year":"2003","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1001\/archinte.166.8.902","article-title":"Effects of etanercept in patients with the metabolic syndrome","volume":"166","author":"Bernstein","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1159\/000088261","article-title":"Metabolic and vascular effects of tumor necrosis factor-alpha blockade with etanercept in obese patients with type 2 diabetes","volume":"42","author":"Dominguez","year":"2005","journal-title":"J Vasc Res"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/03009740601179605","article-title":"Insulin resistance in patients with rheumatoid arthritis: effect of anti-TNFalpha therapy","volume":"36","author":"Rosenvinge","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2337\/diab.45.7.881","article-title":"Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM","volume":"45","author":"Ofei","year":"1996","journal-title":"Diabetes"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB66|cit66","first-page":"1316","article-title":"No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin-resistant patients","volume":"85","author":"Paquot","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"E102","DOI":"10.1152\/ajpendo.00089.2007","article-title":"Effects of TNF-alpha neutralization on adipocytokines and skeletal muscle adiposity in the metabolic syndrome","volume":"293","author":"Lo","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1126\/science.3086977","article-title":"Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans","volume":"232","author":"Bendtzen","year":"1986","journal-title":"Science"},{"issue":"Suppl 3","key":"10.1111\/j.1365-2796.2010.02313.x-BIB69|cit69","first-page":"67","article-title":"Beta-cells in type 2 diabetes: a loss of function and mass","volume":"62","author":"Maedler","year":"2004","journal-title":"Horm Res"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/eurjhf\/hfq017","article-title":"Interleukin-1beta modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouse","volume":"12","author":"Abbate","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.amjcard.2009.12.059","article-title":"Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction","volume":"105","author":"Abbate","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1161\/CIRCULATIONAHA.107.740233","article-title":"Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction","volume":"117","author":"Abbate","year":"2008","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/RHU.0b013e3181be2423","article-title":"IL-1 inhibition with anakinra in a patient with refractory gout","volume":"15","author":"Singh","year":"2009","journal-title":"J Clin Rheumatol"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/ar2143","article-title":"A pilot study of IL-1 inhibition by anakinra in acute gout","volume":"9","author":"So","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrrheum.2009.236","article-title":"Update on gout: new therapeutic strategies and options","volume":"6","author":"Terkeltaub","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1136\/ard.2009.108936","article-title":"The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study","volume":"68","author":"Terkeltaub","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00296-005-0617-7","article-title":"Successful treatment of chronic tophaceous gout with infliximab (Remicade)","volume":"26","author":"Fiehn","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1172\/JCI28075","article-title":"MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals","volume":"116","author":"Chen","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1002\/art.27667","article-title":"Fatty acids engagement with TLR2 drive IL-1beta production via inflammasome activation by urate crystals in gouty arthritis","volume":"62","author":"Joosten","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/ard.2007.082222","article-title":"Crystals of monosodium urate monohydrate enhance lipopolysaccharide-induced release of interleukin 1 beta by mononuclear cells through a caspase 1-mediated process","volume":"68","author":"Giamarellos-Bourboulis","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"10232","DOI":"10.1016\/S0021-9258(18)86936-8","article-title":"Dissociation between interleukin-1\u03b2 mRNA and protein synthesis in human peripheral blood mononuclear cells","volume":"265","author":"Schindler","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1182\/blood.V76.8.1631.1631","article-title":"Recombinant C5a stimulates transcription rather than translation of IL-1 and TNF; cytokine synthesis induced by LPS, IL-1 or PMA","volume":"76","author":"Schindler","year":"1990","journal-title":"Blood"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4049\/jimmunol.153.1.277","article-title":"Peripheral blood mononuclear cells stimulated with C5a or lipopolysaccharide to synthesize equivalent levels of IL-1\u03b2 mRNA show unequal IL-1\u03b2 protein accumulation but similar polyribosome profiles","volume":"153","author":"Kaspar","year":"1994","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/art.1780400525","article-title":"Endothelial activation in monosodium urate monohydrate crystal-induced inflammation: in vitro and in vivo studies on the roles of tumor necrosis factor alpha and interleukin-1","volume":"40","author":"Chapman","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB86|cit86","unstructured":"Kolly L Karababa M Joosten LA Inflammatory role of ASC 2009"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"35279","DOI":"10.1074\/jbc.M706762200","article-title":"A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways","volume":"282","author":"Nguyen","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1002\/art.25006","article-title":"Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta","volume":"60","author":"Joosten","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1056\/NEJMoa070389","article-title":"Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma","volume":"356","author":"Kyle","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB90|cit90","first-page":"868","article-title":"Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors","volume":"24","author":"Torcia","year":"1996","journal-title":"Exp Hematol"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0889-8588(05)70115-5","article-title":"The role of interleukin-1 beta in the pathogenesis of multiple myeloma","volume":"13","author":"Lust","year":"1999","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4065\/84.2.114","article-title":"Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component","volume":"84","author":"Lust","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1091\/mbc.10.5.1463","article-title":"The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles","volume":"10","author":"Andrei","year":"1999","journal-title":"Mol Biol Cell"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"9745","DOI":"10.1073\/pnas.0308558101","article-title":"Phospholipases C and A2 control lysosome-mediated IL-1 beta secretion: implications for inflammatory processes","volume":"101","author":"Andrei","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.4049\/jimmunol.0900578","article-title":"Pathogen-induced interleukin-1beta processing and secretion is regulated by a biphasic redox response","volume":"183","author":"Tassi","year":"2009","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2796.2010.02313.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1182\/blood.V81.10.2492.2492","article-title":"Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event","volume":"81","author":"Kaplanski","year":"1993","journal-title":"Blood"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2796.2010.02313.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2796.2010.02313.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T05:03:10Z","timestamp":1685854990000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2796.2010.02313.x"}},"subtitle":["Key Symposium: Acute and chronic autoinflammatory diseases"],"short-title":[],"issued":{"date-parts":[[2010,12,16]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2796.2010.02313.x","relation":{},"ISSN":["0954-6820"],"issn-type":[{"value":"0954-6820","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12,16]]}}}